Sermonix Pharmaceuticals Company
Sermonix Pharmaceuticals Inc is a privately held, Ohio-based biopharmaceutical company with a precision medicine focus for bringing targeted oncology products through development, approval, and commercialization. Sermonix’s lead candidate is oral lasofoxifene.
Total Funding:
$67,550,000
Headquarters:
Columbus, Ohio, United States
Funding Status:
Early Stage Venture
Employee Number:
1-10
Estimated Revenue:
$10M to $50M
Last Funding Type:
Series A
Last Funding Date:
2021-11-15
Investors Number:
5
Founded Date:
01-01-2014
Industry:
Longevity